English

2023
2022
2021 under construction
2020 under construction
2019 under construction

2018

1. Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.
   Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C.
   Transplant Proc. 2018 Oct;50(8):2553-2557. doi: 10.1016/j.transproceed.2018.02.182. Epub 2018 Mar 20.
2. Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
   Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C.
   Int Urol Nephrol. 2018 Sep 18. doi: 10.1007/s11255-018-1985-8. [Epub ahead of print]
3. Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.
   Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.
   BJU Int. 2018 Sep 14. doi: 10.1111/bju.14535.
4. Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers. Yogesh KV, Kamiyama T, Ohyama C, Yoneyama T, Nouso K, Kimura S, Hinou H, Nishimura SI.
   Medchemcomm. 2018 Jun 29;9(8):1351-1358. doi: 10.1039/c8md00162f. eCollection 2018 Aug 1.
5. Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.
   Koie T, Ohyama C, Yoneyama T, Nagasaka H, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y.
   Int J Med Robot. 2018 Aug 23:e1955. doi: 10.1002/rcs.1955.
6. Can single positive core prostate cancer at biopsy be considered a low-risk disease?
   Yamamoto H, Koie T, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Kawamura S, Kato T, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C.
   Int Urol Nephrol. 2018 Oct;50(10):1829-1833. doi: 10.1007/s11255-018-1966-y. Epub 2018 Aug 20.
7. Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.
   Okamoto T, Tsutaya C, Hatakeyama S, Konishi S, Okita K, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C.
   Int Urol Nephrol. 2018 Sep;50(9):1713-1720. doi: 10.1007/s11255-018-1957-z. Epub 2018 Aug 20.
8. Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association.
   Shiraishi T, Nakamura T, Ukimura O; Cancer Registration Committee of the Japanese Urological Association.
   Int J Urol. 2018 Aug;25(8):730-736. doi: 10.1111/iju.13720. Epub 2018 Jul 17.
9. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
   Okamoto T, Hatakeyama S, Hosogoe S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C.
   PLoS One. 2018 Jul 3;13(7):e0199160. doi: 10.1371/journal.pone.0199160. eCollection 2018.
10. Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
    Hamano I, Hatakeyama S, Nakamura R, Fukuhara R, Noro D, Tanaka T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Yokoyama Y, Ohyama C.
    Int J Urol. 2018 Sep;25(9):817-824. doi: 10.1111/iju.13732. Epub 2018 Jul 2.
11. Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    Momota M, Hatakeyama S, Yamamoto H, Iwamura H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.
    Oncotarget. 2018 May 1;9(33):23047-23057. doi: 10.18632/oncotarget.25198. eCollection 2018 May 1.
12. Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.
    Iwamura H, Hatakeyama S, Sato M, Ohyama C.
    Med Oncol. 2018 May 9;35(6):94. doi: 10.1007/s12032-018-1152-1. Review.
13. Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.
    Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.
    Eur Urol Focus. 2018 May 4. pii: S2405-4569(18)30107-X. doi: 10.1016/j.euf.2018.04.017.
14. Two years of bicalutamide monotherapy in patients with biochemical relapse after radical prostatectomy.
    Okubo T, Mitsuzuka K, Koie T, Hoshi S, Matsuo S, Saito S, Tsuchiya N, Habuchi T, Ohyama C, Arai Y; Michinoku Urological Cancer Study Group.
    Jpn J Clin Oncol. 2018 Jun 1;48(6):570-575. doi: 10.1093/jjco/hyy060.
15. Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.
    Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.
    Oncotarget. 2018 Apr 3;9(25):17396-17405. doi: 10.18632/oncotarget.24712. eCollection 2018 Apr 3.
16. Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report.
    Kido K, Hatakeyama S, Hamano I, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Tomita H, Suzuki T, Narumi S, Ohyama C.
    Transplant Proc. 2018 Apr;50(3):898-901. doi: 10.1016/j.transproceed.2018.01.015.
17. Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.
    Okamoto T, Hatakeyama S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Koie T, Suzuki T, Ohyama C.
    Clin Exp Nephrol. 2018 Oct;22(5):1174-1181. doi: 10.1007/s10157-018-1569-z. Epub 2018 Mar 29.
18. A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation.
    Kodama H, Hatakeyama S, Matsumoto T, Tanaka T, Horiguchi H, Kubota Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Case Rep Urol. 2018 Jan 17;2018:6904827. doi: 10.1155/2018/6904827. eCollection 2018.
19. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
    Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B; CheckMate 214 Investigators.
    N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.
20. The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.
    Okamoto T, Hatakeyama S, Kodama H, Horiguchi H, Kubota Y, Kido K, Momota M, Hosogoe S, Tanaka Y, Takashima T, Saitoh F, Suzuki T, Ohyama C.
    BMC Nephrol. 2018 Mar 20;19(1):71. doi: 10.1186/s12882-018-0872-y.
21. The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.
    Momota M, Hatakeyama S, Tokui N, Sato T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narita S, Kawaguchi T, Ohyama C.
    Eur Urol Focus. 2018 Mar 13. pii: S2405-4569(18)30081-6. doi: 10.1016/j.euf.2018.03.003.
22. Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.
    Horiguchi H, Hatakeyama S, Anan G, Kubota Y, Kodama H, Momota M, Kido K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Sato M, Ohyama C.
    Oncotarget. 2018 Jan 4;9(9):8746-8755. doi: 10.18632/oncotarget.23982.
23. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
    Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C.
    Med Oncol. 2018 Feb 26;35(4):41. doi: 10.1007/s12032-018-1102-y.
24. Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.
    Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.
    Int J Clin Oncol. 2018 Aug;23(4):726-733. doi: 10.1007/s10147-018-1248-9. Epub 2018 Feb 12.
25. Onco-testicular sperm extraction (Onco-TESE) from a single testis with metachronous bilateral testicular cancer: a case report.
    Hamano I, Hatakeyama S, Nakamura R, Fukuhara R, Noro D, Seino H, Yoneyama T, Hashimoto Y, Koie T, Yokoyama Y, Ohyama C.
    Basic Clin Androl. 2018 Jan 25;28:1. doi: 10.1186/s12610-018-0066-2. eCollection 2018.
26. Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney Transplantation.
    Mursawa H, Hatakeyama S, Yamamoto H, Tanaka Y, Soma O, Matsumoto T, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Saitoh H, Suzuki T, Narumi S, Ohyama C.
    Transplant Proc. 2018 Jan - Feb;50(1):145-149. doi: 10.1016/j.transproceed.2017.12.011.

2017

1. Delirium in hemodialysis predicts mortality: a single-center, long-term observational study.
   Yasui-Furukori N, Tarakita N, Uematsu W, Saito H, Nakamura K, Ohyama C, Sugawara N.
   Neuropsychiatr Dis Treat. 2017 Dec 14;13:3011-3016. doi: 10.2147/NDT.S152355. eCollection 2017.
   PMID: 29276387 Free PMC Article
   
2. Fertility preservation of patients with testicular cancer.
   Hamano I, Hatakeyama S, Ohyama C.
   Reprod Med Biol. 2017 May 18;16(3):240-251. doi: 10.1002/rmb2.12037. eCollection 2017 Jul. Review.
   PMID: 29259474 Free PMC Article
   
3. Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.
   Kubota Y, Hatakeyama S, Tanaka T, Fujita N, Iwamura H, Mikami J, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C.
   Oncotarget. 2017 Oct 6;8(60):101500-101508. doi: 10.18632/oncotarget.21551. eCollection 2017 Nov 24.
   PMID: 29254181 Free PMC Article
   
4. Longer recurrence-free survival in a patient with metastatic renal cell carcinoma treated with temsirolimus.
   Satoh T, Koie T, Horiguchi H, Tokui N, Narita S, Ohyama C.
   Clin Case Rep. 2017 Oct 18;5(12):1950-1953. doi: 10.1002/ccr3.1181. eCollection 2017 Dec.
   PMID: 29225833 Free PMC Article
   
5. Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.
   Tanaka T, Yoneyama T, Noro D, Imanishi K, Kojima Y, Hatakeyama S, Tobisawa Y, Mori K, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Tanaka M, Nishimura SI, Kurauchi S, Takahashi I, Ohyama C.
   Int J Mol Sci. 2017 Dec 6;18(12). pii: E2632. doi: 10.3390/ijms18122632.
   PMID: 29210993 Free PMC Article
   
6. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.
   Hirose K, Aoki M, Sato M, Akimoto H, Hashimoto Y, Imai A, Kamimura N, Kawaguchi H, Hatayama Y, Fujioka I, Tanaka M, Ohyama C, Takai Y.
   Radiat Oncol. 2017 Dec 1;12(1):192. doi: 10.1186/s13014-017-0932-7.
   PMID: 29191234 Free PMC Article
   
7. Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
   Noro D, Koie T, Hashimoto Y, Tanaka T, Ohyama C, Tobisawa Y, Yoneyama T, Imai A, Hatakeyama S, Yamamoto H, Kitayama M, Hirota K.
   Jpn J Clin Oncol. 2018 Feb 1;48(2):184-189. doi: 10.1093/jjco/hyx168.
   PMID: 29177431
   
8. Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.
   Anan G, Hatakeyama S, Fujita N, Iwamura H, Tanaka T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Sato M, Ohyama C.
   Oncotarget. 2017 Sep 18;8(49):86130-86142. doi: 10.18632/oncotarget.20991. eCollection 2017 Oct 17.
   PMID: 29156782 Free PMC Article
   
9. Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
   Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C.
   Oncotarget. 2017 Aug 24;8(47):83183-83194. doi: 10.18632/oncotarget.20554. eCollection 2017 Oct 10.
   PMID: 29137333 Free PMC Article
   
10. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
    Matsumoto T, Hatakeyama S, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Yamashita S, Narita T, Koie T, Kawamura S, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C.
    Med Oncol. 2017 Oct 31;34(12):190. doi: 10.1007/s12032-017-1050-y.
    PMID: 29090390
    
11. The role of LIM and SH3 protein-1 in bladder cancer metastasis.
    Sato M, Yoneyama MS, Hatakeyama S, Funyu T, Suzuki T, Ohyama C, Tsuboi S.
    Oncol Lett. 2017 Oct;14(4):4829-4834. doi: 10.3892/ol.2017.6802. Epub 2017 Aug 23.
    PMID: 29085487 Free PMC Article
    
12. Opacity of big toenail predicts poor prognosis in patients with end-stage renal disease on hemodialysis.
    Soma O, Hatakeyama S, Matsumoto T, Tanaka T, Tanaka Y, Hosogoe S, Kodama H, Horiguchi H, Kubota Y, Kido K, Momota M, Anan G, Narita I, Kitahara R, Saitoh H, Suzuki T, Ohyama C.
    Clin Exp Nephrol. 2018 Jun;22(3):668-676. doi: 10.1007/s10157-017-1495-5. Epub 2017 Oct 25.
    PMID: 29071506
    
13. Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
    Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C.
    Oncotarget. 2017 Jul 6;8(39):65492-65505. doi: 10.18632/oncotarget.19043. eCollection 2017 Sep 12.
    PMID: 29029448 Free PMC Article
    
14. Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
    Hamano I, Hatakeyama S, Iwamurau H, Fujita N, Fukushi K, Narita T, Hagiwara K, Kusaka A, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C.
    Oncotarget. 2017 May 29;8(37):61404-61414. doi: 10.18632/oncotarget.18248. eCollection 2017 Sep 22.
15. Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
    Tanaka T, Koie T, Ohyama C, Hashimoto Y, Imai A, Tobisawa Y, Hatakeyama S, Yamamoto H, Yoneyama T, Horiguchi H, Kodama H, Yoneyama T.
    Jpn J Clin Oncol. 2017 Nov 1;47(11):1078-1082. doi: 10.1093/jjco/hyx119.
    PMID: 28973396
    
16. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
    Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain S, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Hegemann M, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Del Muro XG, Rodriguez-Vida A, Cicin I, Harputluoglu H, Widau RC, Liepa AM, Walgren RA, Hamid O, Zimmermann AH, Bell-McGuinn KM, Powles T; RANGE study investigators.
    Lancet. 2017 Nov 18;390(10109):2266-2277. doi: 10.1016/S0140-6736(17)32365-6. Epub 2017 Sep 12.
    PMID: 28916371
    
17. Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.
    Narita T, Hatakeyama S, Koie T, Hosogoe S, Matsumoto T, Soma O, Yamamoto H, Yoneyama T, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C.
    BMC Urol. 2017 Aug 31;17(1):72. doi: 10.1186/s12894-017-0263-x.
    PMID: 28859643 Free PMC Article
    Similar articles
    Select item 28786963
18. Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.
    Noro D, Yoneyama T, Hatakeyama S, Tobisawa Y, Mori K, Hashimoto Y, Koie T, Tanaka M, Nishimura SI, Sasaki H, Saito M, Harada H, Chikaraishi T, Ishida H, Tanabe K, Satoh S, Ohyama C.
    Int J Mol Sci. 2017 Aug 8;18(8). pii: E1731. doi: 10.3390/ijms18081731.
    PMID: 28786963 Free PMC Article
    Similar articles
    Select item 28759644
19. The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.
    Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C.
    PLoS One. 2017 Jul 31;12(7):e0182136. doi: 10.1371/journal.pone.0182136. eCollection 2017.
    PMID: 28759644 Free PMC Article
    
20. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Eur Urol Focus. 2017 Apr 7. pii: S2405-4569(17)30081-0. doi: 10.1016/j.euf.2017.03.013. [Epub ahead of print]
    PMID: 28753881 Free Article
    
21. Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
    Oikawa M, Hatakeyama S, Yoneyma T, Tobisawa Y, Narita T, Yamamoto H, Hashimoto Y, Koie T, Narita S, Sasaki A, Tsuchiya N, Habuchi T, Takahashi I, Nakaji S, Ohyama C.
    Eur Urol Focus. 2018 Apr;4(3):405-411. doi: 10.1016/j.euf.2016.11.004. Epub 2016 Nov 22.
    PMID: 28753809
    
22. Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.
    Tanaka Y, Hatakeyama S, Hosogoe S, Tanaka T, Hamano I, Kusaka A, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Int J Clin Oncol. 2018 Feb;23(1):134-141. doi: 10.1007/s10147-017-1169-z. Epub 2017 Jul 27.
    PMID: 28752352
    
23. Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
    Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y.
    Int J Clin Oncol. 2017 Dec;22(6):1087-1093. doi: 10.1007/s10147-017-1160-8. Epub 2017 Jul 5.
    PMID: 28681153
    
24. Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.
    Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Tanaka Y, Hagiwara K, Hirai H, Morohashi S, Kijima H, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Oncotarget. 2017 Jul 25;8(30):49749-49756. doi: 10.18632/oncotarget.17930.
    PMID: 28572534 Free PMC Article
    
25. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J, Kuroiwa K, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yamaguchi A, Matsuyama H, Ichikawa T, Asano T, Mizusawa J, Eba J, Naito S.
    World J Urol. 2017 Nov;35(11):1737-1744. doi: 10.1007/s00345-017-2049-x. Epub 2017 May 15.
    PMID: 28508102
    
26. Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
    Noro D, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kawaguchi T, Ohyama C.
    Med Oncol. 2017 Jun;34(6):117. doi: 10.1007/s12032-017-0977-3. Epub 2017 May 12.
    PMID: 28500617
    
27. Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association.
    Inokuchi J, Eto M, Hara T, Fujimoto H, Nishiyama H, Miyazaki J, Kikuchi E, Hinotsu S, Koie T, Ohyama C; Cancer Registration Committee of the Japanese Urological Association.
    Jpn J Clin Oncol. 2017 Jul 1;47(7):652-659. doi: 10.1093/jjco/hyx051.
    PMID: 28398494
    
28. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C.
    Med Oncol. 2017 May;34(5):90. doi: 10.1007/s12032-017-0955-9. Epub 2017 Apr 10.
    PMID: 28397105
    
29. Clinical relevance of aortic calcification in urolithiasis patients.
    Tanaka T, Hatakeyama S, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C.
    BMC Urol. 2017 Apr 4;17(1):25. doi: 10.1186/s12894-017-0218-2.
    PMID: 28376750 Free PMC Article
    
30. Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer.
    Osamu S, Murasawa H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Case Rep Urol. 2017;2017:3594914. doi: 10.1155/2017/3594914. Epub 2017 Feb 26.
    PMID: 28337357 Free PMC Article
    
31. Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
    Narita T, Hatakeyama S, Yoneyama T, Narita S, Yamashita S, Mitsuzuka K, Sakurai T, Kawamura S, Tochigi T, Takahashi I, Nakaji S, Tobisawa Y, Yamamoto H, Koie T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C.
    Cancer Med. 2017 Apr;6(4):739-748. doi: 10.1002/cam4.1035. Epub 2017 Mar 20.
    PMID: 28317343 Free PMC Article
    
32. Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.
    Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Int J Urol. 2017 May;24(5):361-366. doi: 10.1111/iju.13318. Epub 2017 Mar 4.
    PMID: 28258623 Free Article
    
33. A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase.
    Yamamoto H, Tobisawa Y, Inubushi T, Irie F, Ohyama C, Yamaguchi Y.
    J Biol Chem. 2017 May 5;292(18):7304-7313. doi: 10.1074/jbc.M116.770149. Epub 2017 Feb 28.
    PMID: 28246172 Free PMC Article
    
34. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
    Ishikawa T, Yoneyama T, Tobisawa Y, Hatakeyama S, Kurosawa T, Nakamura K, Narita S, Mitsuzuka K, Duivenvoorden W, Pinthus JH, Hashimoto Y, Koie T, Habuchi T, Arai Y, Ohyama C.
    Int J Mol Sci. 2017 Feb 22;18(2). pii: E470. doi: 10.3390/ijms18020470.
35. Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.
    Hagiwara K, Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Tobisawa Y, Yoneyama T.
    Int Urol Nephrol. 2017 May;49(5):811-816. doi: 10.1007/s11255-017-1546-6. Epub 2017 Feb 17.
    PMID: 28213801
    
36. Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.
    Fukushi K, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Soma O, Matsumoto T, Hamano I, Narita T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Terayama Y, Funyu T, Ohyama C.
    BMC Urol. 2017 Feb 6;17(1):13. doi: 10.1186/s12894-017-0202-x.
    PMID: 28166753 Free PMC Article
    
37. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
    Hagiwara K, Tobisawa Y, Kaya T, Kaneko T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Suda Y, Ohyama C, Yoneyama T.
    Int J Mol Sci. 2017 Jan 26;18(2). pii: E261. doi: 10.3390/ijms18020261.
    PMID: 28134773 Free PMC Article
    
38. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
    Sharma P, Retz M, Siefker-Radtke A, Baron A, Necchi A, Bedke J, Plimack ER, Vaena D, Grimm MO, Bracarda S, Arranz JÁ, Pal S, Ohyama C, Saci A, Qu X, Lambert A, Krishnan S, Azrilevich A, Galsky MD.
    Lancet Oncol. 2017 Mar;18(3):312-322. doi: 10.1016/S1470-2045(17)30065-7. Epub 2017 Jan 26.
    PMID: 28131785
    
39. A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.
    Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Sato M, Tone K, Tatara Y, Kakizaki I, Funyu T, Fukuda M, Hoshi S, Ohyama C, Tsuboi S.
    J Biochem. 2017 Jun 1;161(6):479-492. doi: 10.1093/jb/mvw096.
    PMID: 28011817
    
40. The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
    Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Yamauchi A, Shimazui T, Ohtani M.
    Jpn J Clin Oncol. 2017 Mar 1;47(3):252-256. doi: 10.1093/jjco/hyw191.
    PMID: 27980085
    
41. Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.
    Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Soma O, Matsumoto T, Tobisawa Y, Yoneyama T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Int J Clin Oncol. 2017 Apr;22(2):366-372. doi: 10.1007/s10147-016-1071-0. Epub 2016 Dec 8.
    PMID: 27933402
    
42. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T, Tanaka Y; Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol. 2017 Feb;24(2):124-128. doi: 10.1111/iju.13268. Epub 2016 Dec 4.
    PMID: 27915468 Free Article
    
43. The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
    Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C.
    Med Oncol. 2017 Jan;34(1):1. Epub 2016 Nov 26.

2016

1. patients requiring temporary discontinuation of antithrombotic agents.
   Hamano I, Hatakeyama S, Yoneyama T, Tobisawa Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
   Springerplus. 2016 Nov 4;5(1):1917. eCollection 2016.
   PMID: 27867824 Free PMC Article
   Similar articles
   Select item 27730440
2. Recent progress and perspectives on prostate cancer biomarkers.
   Hatakeyama S, Yoneyama T, Tobisawa Y, Ohyama C.
   Int J Clin Oncol. 2017 Apr;22(2):214-221. doi: 10.1007/s10147-016-1049-y. Epub 2016 Oct 11. Review.
   PMID: 27730440 Free PMC Article
   Similar articles
   Select item 27631882
3. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
   Hirose K, Aoki M, Sato M, Akimoto H, Hashimoto Y, Imai A, Kamimura N, Kawaguchi H, Hatayama Y, Fujioka I, Tanaka M, Ohyama C, Takai Y.
   Jpn J Radiol. 2016 Nov;34(11):718-723. Epub 2016 Sep 8.
   PMID: 27631882
   Similar articles
   Select item 27534866
4. The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
   Murasawa H, Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Iwabuchi I, Ogasawara M, Kawaguchi T.
   Int J Clin Oncol. 2017 Feb;22(1):159-165. doi: 10.1007/s10147-016-1029-2. Epub 2016 Aug 17.
   PMID: 27534866
   Similar articles
   Select item 27452497
5. [Management of High-Risk Prostate Cancer and Left Ectopic Ureter Inserting into Seminal Vesicle with Ipsilateral Hypoplastic Kidney of a Young Patient : A Case Report].
   Matsumoto T, Koie T, Soma O, Kusaka A, Hosogoe S, Hamano I, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
   Hinyokika Kiyo. 2016 Jun;62(6):329-33. Review. Japanese.
   PMID: 27452497 Free Article
   Similar articles
   Select item 27374472
6. Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.
   Kubota Y, Nakaigawa N; Committee for Establishment of the Clinical Practice Guideline for the Management of Bladder Cancer and the Japanese Urological Association.
   Int J Urol. 2016 Aug;23(8):640-5. doi: 10.1111/iju.13141. Epub 2016 Jul 3.
   PMID: 27374472 Free Article
   Similar articles
   Select item 27344774
7. [Postoperative complications and management after radical prostatectomy].
   Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
   Nihon Rinsho. 2016 May 20;74 Suppl 3:456-60. Japanese. No abstract available.
   PMID: 27344774
   Similar articles
   Select item 27344727
8. [Development of promising biomarkers for prostate cancer].
   Yoneyama T, Ohyama C.
   Nihon Rinsho. 2016 May 20;74 Suppl 3:191-5. Japanese. No abstract available.
   PMID: 27344727
   Similar articles
   Select item 27234717
9. Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation.
   Oikawa M, Hatakeyama S, Narita T, Yamamoto H, Hosogoe S, Imai A, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Saitoh H, Funyu T, Narumi S, Ohyama C.
   Transplant Proc. 2016 Apr;48(3):701-5. doi: 10.1016/j.transproceed.2015.09.067.
   PMID: 27234717
   Similar articles
   Select item 27195288
10. Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.
    Hagiwara K, Koie T, Iwamura H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
    Biomed Res Int. 2016;2016:4975851. doi: 10.1155/2016/4975851. Epub 2016 Apr 18.
    PMID: 27195288 Free PMC Article
    Similar articles
    Select item 27145178
11. Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
    Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C.
    PLoS One. 2016 May 4;11(5):e0153961. doi: 10.1371/journal.pone.0153961. eCollection 2016.
12. Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
    Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C.
    PLoS One. 2016 Mar 15;11(3):e0151742. doi: 10.1371/journal.pone.0151742. eCollection 2016. No abstract available.
    PMID: 26978781 Free PMC Article
    Similar articles
    Select item 26962246
13. A prospective multicenter study of intermittent chemotherapy with docetaxel and prednisolone for castration-resistant prostate cancer.
    Narita S, Koie T, Yamada S, Orikasa K, Matsuo S, Aoki H, Ishidoya S, Hoshi S, Tsuchiya N, Ohyama C, Arai Y, Habuchi T.
    Jpn J Clin Oncol. 2016 Mar 8. pii: hyw021. [Epub ahead of print]
    PMID: 26962246
    Similar articles
    Select item 26901860
14. Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
    Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C.
    PLoS One. 2016 Feb 22;11(2):e0149544. doi: 10.1371/journal.pone.0149544. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151742.
    PMID: 26901860 Free PMC Article
    Similar articles
    Select item 26851754
15. Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.
    Koie T, Ohyama C, Fujimoto H, Nishiyama H, Miyazaki J, Hinotsu S, Kikuchi E, Sakura M, Inokuchi J, Hara T; Cancer Registration Committee of the Japanese Urological Association, Ohyama C, Nishiyama H, Fujisawa M, Uemura H, Fujimoto H, Suzuki K, Eto M, Hara I, Matsubara A, Nonomura N, Nakanishi H, Koie T, Kanayama H, Miki T, Fukumori T, Naito S; Cancer Registration Committee of the Japanese Urological Association.
    Jpn J Clin Oncol. 2016 May;46(5):468-74. doi: 10.1093/jjco/hyw005. Epub 2016 Feb 6.
    PMID: 26851754
    Similar articles
    Select item 26840556
16. Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.
    Fujita N, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nigawara T, Ohyama C.
    Int J Urol. 2016 May;23(5):412-7. doi: 10.1111/iju.13060. Epub 2016 Feb 2.
    PMID: 26840556 Free Article
    Similar articles
    Select item 26793890
17. [Multimodality therapy for high-risk prostate cancer].
    Hatakeyama S, Ohyama C.
    Nihon Rinsho. 2016 Jan;74(1):114-9. Japanese.
    P MID: 26793890
    Similar articles
    Select item 26768364
18. Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.
    Sato T, Yoneyama T, Tobisawa Y, Hatakeyama S, Yamamoto H, Kojima Y, Mikami J, Mori K, Hashimoto Y, Koie T, Ohyama C.
    Biochem Biophys Res Commun. 2016 Jan 29;470(1):150-156. doi: 10.1016/j.bbrc.2016.01.011. Epub 2016 Jan 6.
    PMID: 26768364
    Similar articles
    Select item 26678556
19. I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.
    Mikami J, Tobisawa Y, Yoneyama T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M.
    Cancer Sci. 2016 Mar;107(3):359-68. doi: 10.1111/cas.12859. Epub 2016 Feb 10.
    PMID: 26678556 Free PMC Article
    Similar articles
    Select item 26669358
20. Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association.
    Miyazaki J, Nishiyama H, Fujimoto H, Ohyama C, Koie T, Hinotsu S, Kikuchi E, Sakura M, Inokuchi J, Hara T.
    J Endourol. 2016 May;30(5):520-5. doi: 10.1089/end.2015.0757. Epub 2016 Jan 28.
    PMID: 26669358
    Similar articles
    Select item 26659912
21. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Inokuchi J, Naito S, Fujimoto H, Hara T, Sakura M, Nishiyama H, Miyazaki J, Kikuchi E, Hinotsu S, Koie T, Ohyama C; Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol. 2016 Mar;23(3):224-30. doi: 10.1111/iju.13031. Epub 2015 Dec 14.
    PMID: 26659912 Free Article
    Similar articles
    Select item 26643109
22. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
    BMC Urol. 2015 Dec 7;15:120. doi: 10.1186/s12894-015-0115-5.
    PMID: 26643109 Free PMC Article
    Similar articles
    Select item 26581246
23. An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.
    Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K.
    Clin Cancer Res. 2016 Jan 1;22(1):54-60. doi: 10.1158/1078-0432.CCR-15-1265. Epub 2015 Nov 18.
    PMID: 26581246 Free Article
    Similar articles
    Select item 26503109
24. Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer.
    Mitsuzuka K, Kyan A, Sato T, Orikasa K, Miyazato M, Aoki H, Kakoi N, Narita S, Koie T, Namima T, Toyoda S, Fukushi Y, Habuchi T, Ohyama C, Arai Y; Tohoku Evidence-Based Medicine Study Group; Michinoku Urological Cancer Study Group.
    Prostate Cancer Prostatic Dis. 2016 Mar;19(1):57-62. doi: 10.1038/pcan.2015.50. Epub 2015 Oct 27.

2015

1. Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
   Kojima Y, Yoneyama T, Hatakeyama S, Mikami J, Sato T, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M, Tobisawa Y.
   PLoS One. 2015 Sep 21;10(9):e0138520. doi: 10.1371/journal.pone.0138520. eCollection 2015.
   PMID: 26390303 Free PMC Article
   Similar articles
   Select item 26332059
2. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association.
   Kanayama HO, Fukumori T, Fujimoto H, Nakanishi H, Ohyama C, Suzuki K, Nishiyama H, Eto M, Miki T, Kamoi K, Kubota Y, Takahashi S, Homma Y, Naito S.
   Int J Urol. 2015 Sep;22(9):S1-7. doi: 10.1111/iju.12826.
   PMID: 26332059 Free Article
   Similar articles
   Select item 26290306
3. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
   Narita S, Mitsuzuka K, Tsuchiya N, Koie T, Kawamura S, Ohyama C, Tochigi T, Yamaguchi T, Arai Y, Habuchi T; Michinoku Japan Urological Cancer Study Group.
   Int J Urol. 2015 Nov;22(11):1029-35. doi: 10.1111/iju.12898. Epub 2015 Aug 20.
   PMID: 26290306 Free Article
   Similar articles
   Select item 26242807
4. Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
   Hara T, Fujimoto H, Sakura M, Inokuchi J, Nishiyama H, Miyazaki J, Ohyama C, Koie T, Kikuchi E, Hinotsu S; Cancer Registration Committee of the Japanese Urological Association.
   Int J Urol. 2015 Nov;22(11):1013-20. doi: 10.1111/iju.12884. Epub 2015 Aug 4.
   PMID: 26242807 Free Article
   Similar articles
   Select item 26238570
5. Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi-institutional national database.
   Miyazaki J, Nishiyama H, Fujimoto H, Ohyama C, Koie T, Hinotsu S, Kikuchi E, Sakura M, Inokuchi J, Hara T; Cancer Registration Committee of the Japanese Urological Association.
   Int J Urol. 2015 Nov;22(11):1023-7. doi: 10.1111/iju.12886. Epub 2015 Aug 4.
   PMID: 26238570 Free Article
   Similar articles
   Select item 26223693
6. Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
   Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K.
   Int J Clin Oncol. 2016 Apr;21(2):379-383. doi: 10.1007/s10147-015-0880-x. Epub 2015 Jul 30.
   PMID: 26223693
   Similar articles
   Select item 26171272
7. Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy.
   Hosogoe S, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C, Aoki M.
   Case Rep Urol. 2015;2015:839738. doi: 10.1155/2015/839738. Epub 2015 Jun 11.
8. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
   Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K.
   Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7.
   PMID: 26149637
   Similar articles
   Select item 26044038
9. Correction for Ye et al., Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome Inhibition.
   Ye P, Mimura J, Okada T, Sato H, Liu T, Maruyama A, Ohyama C, Itoh K.
   Mol Cell Biol. 2015 Jul;35(13):2366. doi: 10.1128/MCB.00404-15. No abstract available.
   PMID: 26044038 Free PMC Article
   Similar articles
   Select item 26007690
10. Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.
    Yoneyama T, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C.
    Int J Clin Oncol. 2015 Dec;20(6):1179-84. doi: 10.1007/s10147-015-0846-z. Epub 2015 May 26.
    PMID: 26007690
    Similar articles
    Select item 25959857
11. Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan.
    Mitsuzuka K, Koga H, Sugimoto M, Arai Y, Ohyama C, Kakehi Y, Naito S.
    Int J Urol. 2015 Aug;22(8):754-9. doi: 10.1111/iju.12813. Epub 2015 May 10.
    PMID: 25959857 Free Article Similar articles
    Select item 25887125
12. Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.
    Koie T, Ohyama C, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K.
    BMC Urol. 2015 Apr 16;15:32. doi: 10.1186/s12894-015-0027-4.
    PMID: 25887125 Free PMC Article
    Similar articles
    Select item 25685590
13. A case of primary renal carcinoid tumor.
    Tanaka T, Yamamoto H, Imai A, Shingo H, Yoneyama T, Koie T, Hashimoto Y, Ohyama C.
    Case Rep Urol. 2015;2015:736213. doi: 10.1155/2015/736213. Epub 2015 Jan 22.
    PMID: 25685590 Free PMC Article
    Similar articles
    Select item 25681879
14. Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.
    Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y.
    Int J Clin Oncol. 2015 Oct;20(5):1018-25. doi: 10.1007/s10147-015-0802-y. Epub 2015 Feb 15.
    PMID: 25681879
    Similar articles
    Select item 25511947
15. [Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].
    Noro D, Yoneyama T, Hagiwara K, Mori K, Yamamoto H, Hashimoto Y, Koie T, Ohyama C.
    Hinyokika Kiyo. 2014 Nov;60(11):579-82. Japanese.
    PMID: 25511947 Free Article
    Similar articles
    Select item 25471790
16. Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.
    Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y.
    Med Oncol. 2015 Jan;32(1):421. doi: 10.1007/s12032-014-0421-x. Epub 2014 Dec 4.
    PMID: 25471790
    Similar articles
    Select item 25408658
17. Testicular metastasis of prostate cancer: a case report.
    Kusaka A, Koie T, Yamamoto H, Hamano I, Yoneyama T, Hashimoto Y, Ohyama C, Tobisawa Y, Yoneyama T.
    Case Rep Oncol. 2014 Sep 18;7(3):643-7. doi: 10.1159/000367779. eCollection 2014 Sep.
    PMID: 25408658 Free PMC Article
    Similar articles
    Select item 25330857
18. Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin.
    Mitsuzuka K, Narita S, Koie T, Kaiho Y, Tsuchiya N, Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y.
    Prostate Cancer Prostatic Dis. 2015 Mar;18(1):25-30. doi: 10.1038/pcan.2014.40. Epub 2014 Oct 21.
    PMID: 25330857
    Similar articles
    Select item 25243652
19. Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary--Japanese Urological Association, 2014 edition).
    Oya M, Kikuchi E; Committee for Establishment of Clinical Practice Guideline for Management of Upper Tract Urothelial Carcinoma; Japanese Urological Association.
    Int J Urol. 2015 Jan;22(1):3-13. doi: 10.1111/iju.12630. Epub 2014 Sep 21.
    PMID: 25243652 Free Article
    Similar articles
    Select item 25165894
20. A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens.
    Koie T, Mitsuzuka K, Narita S, Yoneyama T, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C.
    Scand J Urol. 2015 Apr;49(2):103-7. doi: 10.3109/21681805.2014.951959. Epub 2014 Aug 28.

2014

1. Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.
   Ishibashi Y, Tobisawa Y, Hatakeyama S, Ohashi T, Tanaka M, Narita S, Koie T, Habuchi T, Nishimura S, Ohyama C, Yoneyama T.
   Prostate. 2014 Nov;74(15):1521-9. doi: 10.1002/pros.22869. Epub 2014 Aug 23.
   PMID: 25154914
   Similar articles
   Select item 25115632
2. Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy.
   Koie T, Mitsuzuka K, Narita S, Yoneyama T, Kawamura S, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C.
   Int J Urol. 2015 Jan;22(1):70-3. doi: 10.1111/iju.12597. Epub 2014 Aug 13.
   PMID: 25115632 Free Article
   Similar articles
   Select item 25090932
3. Primary leiomyosarcoma of a horseshoe kidney in a woman with Turner syndrome: a case report.
   Tanaka T, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.
   BMC Res Notes. 2014 Aug 4;7:491. doi: 10.1186/1756-0500-7-491.
   PMID: 25090932 Free PMC Article
   Similar articles
   Select item 25081056
4. Tubulocystic renal cell carcinoma in the left kidney: a case report.
   Ishibashi Y, Koie T, Fujita N, Satoh T, Mikami J, Hatakeyama S, Ohyama C, Tobisawa Y, Yoneyama T.
   J Med Case Rep. 2014 Jul 31;8:265. doi: 10.1186/1752-1947-8-265. Review.
   PMID: 25081056 Free PMC Article
   Similar articles
   Select item 25002527
5. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.
   Ye P, Mimura J, Okada T, Sato H, Liu T, Maruyama A, Ohyama C, Itoh K.
   Mol Cell Biol. 2014 Sep 15;34(18):3421-34. doi: 10.1128/MCB.00221-14. Epub 2014 Jul 7. Erratum in: Mol Cell Biol. 2015 Jul;35(13):2366.
   PMID: 25002527 Free PMC Article
   Similar articles
   Select item 24951323
6. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
   Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Kitayam M, Hirota K.
   Urol Oncol. 2014 Aug;32(6):820-5. doi: 10.1016/j.urolonc.2014.03.010. Epub 2014 Jun 18.
   PMID: 24951323
   Similar articles
   Select item 24885947
7. Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.
   Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y.
   World J Surg Oncol. 2014 Apr 30;12:134. doi: 10.1186/1477-7819-12-134.
8. Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.
   Yoneyama T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C.
   Int J Clin Oncol. 2015 Apr;20(2):369-74. doi: 10.1007/s10147-014-0706-2. Epub 2014 May 29.
   PMID: 24865474
   Similar articles
   Select item 24814705
9. Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.
   Yoneyama T, Ohyama C, Hatakeyama S, Narita S, Habuchi T, Koie T, Mori K, Hidari KI, Yamaguchi M, Suzuki T, Tobisawa Y.
   Biochem Biophys Res Commun. 2014 Jun 13;448(4):390-6. doi: 10.1016/j.bbrc.2014.04.107. Epub 2014 May 9.
   PMID: 24814705
   Similar articles
   Select item 24810881
10. Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis.
    Sutoh Yoneyama M, Hatakeyama S, Habuchi T, Inoue T, Nakamura T, Funyu T, Wiche G, Ohyama C, Tsuboi S.
    Eur J Cell Biol. 2014 Apr;93(4):157-69. doi: 10.1016/j.ejcb.2014.03.002. Epub 2014 Apr 15.
    PMID: 24810881
    Similar articles
    Select item 24803901
11. Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.
    Narita T, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto T, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C, Hakamada K.
    Case Rep Oncol. 2014 Mar 27;7(1):233-8. doi: 10.1159/000360813. eCollection 2014 Jan.
    PMID: 24803901 Free PMC Article
    Similar articles
    Select item 24803183
12. Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.
    Kanda S, Tsuchiya N, Narita S, Inoue T, Huang M, Chiba S, Akihama S, Saito M, Numakura K, Tsuruta H, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.
    Int J Cancer. 2015 Jan 1;136(1):74-82. doi: 10.1002/ijc.28952. Epub 2014 May 20.
    PMID: 24803183 Free Article
    Similar articles
    Select item 24771079
13. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
    Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y.
    Int J Clin Oncol. 2015 Feb;20(1):176-81. doi: 10.1007/s10147-014-0696-0. Epub 2014 Apr 29.
    PMID: 24771079
    Similar articles
    Select item 24741368
14. Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.
    Koie T, Ohyama C, Mikami J, Iwamura H, Fujita N, Sato T, Kojima Y, Fukushi K, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Kitayama M, Hirota K.
    ScientificWorldJournal. 2014 Mar 4;2014:948305. doi: 10.1155/2014/948305. eCollection 2014.
    PMID: 24741368 Free PMC Article
    Similar articles
    Select item 24735938
15. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
    Park J, Habuchi T, Arai Y, Ohyama C, Inoue T, Hatakeyama S, Jeon SS, Kwon GY, Kwak C, Moon KC, Kim CS, Ahn H.
    J Urol. 2014 Oct;192(4):1064-71. doi: 10.1016/j.juro.2014.04.001. Epub 2014 Apr 13.
    PMID: 24735938
    Similar articles
    Select item 24725194
16. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Miki T, Kamoi K, Fujimoto H, Kanayama HO, Ohyama C, Suzuki K, Nishiyama H, Eto M, Naito S, Fukumori T, Kubota Y, Takahashi S, Mikami K, Homma Y.
    Int J Urol. 2014 Aug;21(8):S1-6. doi: 10.1111/iju.12441. Epub 2014 Apr 13.
    PMID: 24725194 Free Article
    Similar articles
    Select item 24721676
17. Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged <70 and ≥70
    Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y.
    Jpn J Clin Oncol. 2014 Jun;44(6):587-92. doi: 10.1093/jjco/hyu038. Epub 2014 Apr 9.
    PMID: 24721676
    Similar articles
    Select item 24700028
18. Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.
    Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y.
    Med Oncol. 2014 May;31(5):949. doi: 10.1007/s12032-014-0949-9. Epub 2014 Apr 4.
    PMID: 24700028 Free PMC Article
    Similar articles
    Select item 24699942
19. Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells.
    Imanishi K, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.
    Mol Med Rep. 2014 Jun;9(6):2159-65. doi: 10.3892/mmr.2014.2113. Epub 2014 Apr 3.
    PMID: 24699942
    Similar articles
    Select item 24656032
20. Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.
    Sato T, Yoneyama T, Hagiwara K, Narita T, Noro D, Tanaka T, Tanaka Y, Tobisawa Y, Yoneyama T, Yamamoto H, Okamoto A, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C.
    Transplant Proc. 2014;46(2):634-6. doi: 10.1016/j.transproceed.2013.11.022.
    PMID: 24656032
    Similar articles
    Select item 24656027
21. BK virus-associated urothelial carcinoma of a ureter graft in a renal transplant recipient: a case report.
    Oikawa M, Hatakeyama S, Fujita T, Murakami R, Hagiwara K, Narita T, Noro D, Tanaka T, Tanaka Y, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Ohyama C.
    Transplant Proc. 2014;46(2):616-9. doi: 10.1016/j.transproceed.2013.09.037.
    PMID: 24656027
    Similar articles
    Select item 24655995
22. Post-transplant renal function and cardiovascular events are closely associated with the aortic calcification index in renal transplant recipients.
    Imanishi K, Hatakeyama S, Yamamoto H, Okamoto A, Imai A, Yoneyama T, Hashimoto Y, Koie T, Fujita T, Murakami R, Saitoh H, Funyu T, Narumi S, Ohyama C.
    Transplant Proc. 2014;46(2):484-8. doi: 10.1016/j.transproceed.2013.09.039.
    PMID: 24655995
    Similar articles
    Select item 24655984
23. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
    Hatakeyama S, Fujita T, Murakami R, Suzuki Y, Sugiyama N, Yamamoto H, Okamoto A, Imai A, Tobisawa Y, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Ohyama C.
    Transplant Proc. 2014;46(2):445-8. doi: 10.1016/j.transproceed.2013.09.036.
    PMID: 24655984
    Similar articles
    Select item 24653857
24. A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.
    Hagiwara K, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Case Rep Urol. 2014;2014:646743. doi: 10.1155/2014/646743. Epub 2014 Feb 5.
    PMID: 24653857 Free PMC Article
    Similar articles
    Select item 24594771
25. [Capillary hemangioma in renal hilum; a case report].
    Oikawa M, Hatakeyama S, Hamano I, Tanaka T, Tanaka Y, Narita T, Noro D, Hagiwara K, Ohyama C.
    Hinyokika Kiyo. 2014 Jan;60(1):33-7. Japanese.
    PMID: 24594771 Free Article
    Similar articles
    Select item 24549769
26. Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.
    Tokui N, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.
    Mol Med Rep. 2014 Apr;9(4):1142-6. doi: 10.3892/mmr.2014.1965. Epub 2014 Feb 19.
    PMID: 24549769
    Similar articles
    Select item 24528896
27. Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer.
    Kido T, Schubert S, Hatakeyama S, Ohyama C, Schmidtke J, Lau YF.
    Cell Biosci. 2014 Feb 17;4(1):9. doi: 10.1186/2045-3701-4-9.
28. ※エクセル NO140が飛んでいます。
29. A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
    Iwamura H, Hatakeyama S, Tanaka Y, Tanaka T, Tokui N, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Ohyama C.
    BMC Res Notes. 2014 Jan 29;7:64. doi: 10.1186/1756-0500-7-64.
    PMID: 24476098 Free PMC Article
    Similar articles
    Select item 24453820
30. Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.
    Hatakeyama S, Amano M, Tobisawa Y, Yoneyama T, Tsushima M, Hirose K, Yoneyama T, Hashimoto Y, Koie T, Saitoh H, Yamaya K, Funyu T, Nishimura S, Ohyama C.
    ScientificWorldJournal. 2013 Dec 23;2013:268407. doi: 10.1155/2013/268407. eCollection 2013.
    PMID: 24453820 Free PMC Article
    Similar articles
    Select item 24372688
31. Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: the first large population report from the Cancer Registration Committee of the Japanese Urological Association.
    Fujimoto H, Nakanishi H, Miki T, Kanayama HO, Ohyama C, Suzuki K, Nishiyama H, Eto M, Naito S, Fukumori T, Kubota Y, Takahashi S, Homma Y, Kamoi K.
    Int J Urol. 2014 May;21(5):527-34. doi: 10.1111/iju.12367. Epub 2013 Dec 23.

2013

1. Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report.
   Tanaka Y, Koie T, Hatakeyama S, Hashimoto Y, Ohyama C.
   BMC Urol. 2013 Dec 13;13:72. doi: 10.1186/1471-2490-13-72.
   PMID: 24330625 Free PMC Article
   Similar articles
   Select item 24267160
2. Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
   Koie T, Ohyama C, Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y.
   BMC Res Notes. 2013 Nov 24;6:484. doi: 10.1186/1756-0500-6-484.
   PMID: 24267160 Free PMC Article
   Similar articles
   Select item 24228012
3. Prognosis of elderly Japanese patients aged ≥80 years undergoing hemodialysis.
   Hatakeyama S, Murasawa H, Hamano I, Kusaka A, Narita T, Oikawa M, Noro D, Hagiwara K, Ishimura H, Yoneyama T, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C.
   ScientificWorldJournal. 2013 Oct 9;2013:693514. doi: 10.1155/2013/693514. eCollection 2013.
   PMID: 24228012 Free PMC Article
   Similar articles
   Select item 24140550
4. Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.
   Hatakeyama S, Amano M, Tobisawa Y, Yoneyama T, Tsuchiya N, Habuchi T, Nishimura S, Ohyama C.
   J Urol. 2014 Mar;191(3):805-13. doi: 10.1016/j.juro.2013.10.052. Epub 2013 Oct 16.
   PMID: 24140550
   Similar articles
   Select item 24125174
5. Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.
   Hatakeyama S, Yoneyama T, Hamano I, Murasawa H, Narita T, Oikawa M, Hagiwara K, Noro D, Tanaka T, Tanaka Y, Hashimoto Y, Koie T, Ohyama C.
   BMC Urol. 2013 Oct 14;13:47. doi: 10.1186/1471-2490-13-47.
   PMID: 24125174 Free PMC Article
   Similar articles
   Select item 24119202
6. Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.
   Hatakeyama S, Murasawa H, Narita T, Oikawa M, Fujita N, Iwamura H, Mikami J, Kojima Y, Sato T, Fukushi K, Ishibashi Y, Hashimoto Y, Koie T, Saitoh H, Funyu T, Ohyama C.
   BMC Nephrol. 2013 Oct 12;14:222. doi: 10.1186/1471-2369-14-222.
   PMID: 24119202 Free PMC Article
   Similar articles
   Select item 24068712
7. Pathological and oncological outcomes of elderly men with clinically localized prostate cancer.
   Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y.
   Jpn J Clin Oncol. 2013 Dec;43(12):1238-42. doi: 10.1093/jjco/hyt143. Epub 2013 Sep 25.
   PMID: 24068712
   Similar articles
   Select item 24033445
8. Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.
   Ohyama C, Hatakeyama S, Yoneyama T, Koie T.
   Int J Urol. 2014 Jan;21(1):3-4. doi: 10.1111/iju.12230. Epub 2013 Aug 22. No abstract available.
   PMID: 24033445 Free Article
   Similar articles
   Select item 23946871
9. Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes.
   Tsuchiya N, Matsui S, Narita S, Kamba T, Mitsuzuka K, Hatakeyama S, Horikawa Y, Inoue T, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.
   Genes Cancer. 2013 Jan;4(1-2):54-60. doi: 10.1177/1947601913481354.
   PMID: 23946871 Free PMC Article
   Similar articles
   Select item 23945323
10. [Ureteral endometriosis treated by hormonal therapy : a case report].
    Mikami J, Yamamoto H, Okamoto A, Ishimura H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Hinyokika Kiyo. 2013 Jul;59(7):431-4. Japanese.
    PMID: 23945323 Free Article
    Similar articles
    Select item 23945322
11. [Local recurrence of pheochromocytoma associated with von Hippel-Lindau disease 26 years after bilateral adrenalectomy : a case report].
    Fujita N, Mikami J, Murasawa H, Okamoto A, Imai A, Hatakeyama S, Ishimura H, Yoneyama T, Koie T, Kamimura N, Ohyama C, Morohashi S, Kijima H.
    Hinyokika Kiyo. 2013 Jul;59(7):427-30. Japanese.
    PMID: 23945322 Free Article
    Similar articles
    Select item 23945320
12. [Successful control of hyper-cortisolemia due to ACTH-producing thyroid carcinoid by laparoscopic bilateral adrenalectomy : a case report].
    Kojima Y, Kamimura N, Yamamoto H, Murasawa H, Okamoto A, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C.
    Hinyokika Kiyo. 2013 Jul;59(7):419-22. Japanese.
    PMID: 23945320 Free Article
    Similar articles
    Select item 23879169
13. In vivo selection of high-metastatic subline of bladder cancer cell and its characterization.
    Sugiyama N, Yoneyama MS, Hatakeyama S, Yamamoto H, Okamoto A, Koie T, Saitoh H, Yamaya K, Funyu T, Inoue T, Habuchi T, Ohyama C, Tsuboi S.
    Oncol Res. 2013;20(7):289-95.
    PMID: 23879169
    Similar articles
    Select item 23765676
14. Tumor targeting by a carbohydrate ligand-mimicking peptide.
    Hatakeyama S, Shibata TK, Tobisawa Y, Ohyama C, Sugihara K, Fukuda MN.
    Methods Mol Biol. 2013;1022:369-86. doi: 10.1007/978-1-62703-465-4_28.
    PMID: 23765676
    Similar articles
    Select item 23752230
15. Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy.
    Narita S, Mitsuzuka K, Yoneyama T, Tsuchiya N, Koie T, Kakoi N, Kawamura S, Kaiho Y, Ohyama C, Tochigi T, Yamaguchi T, Habuchi T, Arai Y.
    Prostate Cancer Prostatic Dis. 2013 Sep;16(3):271-6. doi: 10.1038/pcan.2013.16. Epub 2013 Jun 11.
    PMID: 23752230
    Similar articles
    Select item 23729494
16. Changes in indications and oncological outcomes of radical prostatectomy after 2000--data from 1268 Japanese patients treated with radical prostatectomy between 2000 and 2009.
    Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Yamaguchi T, Arai Y.
    Jpn J Clin Oncol. 2013 Aug;43(8):821-6. doi: 10.1093/jjco/hyt072. Epub 2013 May 31.
    PMID: 23729494
    Similar articles
    Select item 23710358
17. Gene expression changes in venous segment of overflow arteriovenous fistula.
    Hashimoto Y, Okamoto A, Saitoh H, Hatakeyama S, Yoneyama T, Koie T, Ohyama C.
    Int J Nephrol. 2013;2013:980923. doi: 10.1155/2013/980923. Epub 2013 Apr 27
18. [Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].
    Fukushi K, Koie T, Yamamoto H, Okamoto A, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
    Hinyokika Kiyo. 2013 Apr;59(4):247-50. Japanese.
    PMID: 23635462 Free Article
    Similar articles
    Select item 23633636
19. [Testicular tumor arising in intra-abdominal testis which was not detected at prior orchidopexy : a case report].
    Iwamura H, Hatakeyama S, Fukushi K, Sato T, Kojima Y, Murasawa H, Ishimura H, Yoneyama T, Koie T, Kamimura N, Morobashi S, Kijima H, Ohyama C.
    Hinyokika Kiyo. 2013 Mar;59(3):189-93. Japanese.
    PMID: 23633636 Free Article
    Similar articles
    Select item 23530598
20. Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.
    Tsuchiya N, Narita S, Inoue T, Saito M, Numakura K, Huang M, Hatakeyama S, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.
    BMC Cancer. 2013 Mar 25;13:150. doi: 10.1186/1471-2407-13-150.
    PMID: 23530598 Free PMC Article
    Similar articles
    Select item 23412127
21. [Adult mature teratoma of the testis: a case report].
    Imanishi K, Hatakeyama S, Okamoto T, Suzuki Y, Sugiyama N, Yamamoto H, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Ohyama C.
    Hinyokika Kiyo. 2013 Jan;59(1):57-60. Japanese.
    PMID: 23412127 Free Article Similar articles
    Select item 23387553
22. Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?
    Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y.
    Int J Urol. 2013 Nov;20(11):1092-6. doi: 10.1111/iju.12112. Epub 2013 Feb 6.
    PMID: 23387553 Free Article
    Similar articles
    Select item 23320782
23. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
    Mitsuzuka K, Narita S, Koie T, Kaiho Y, Tsuchiya N, Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Habuchi T, Ohyama C, Arai Y.
    BJU Int. 2013 May;111(6):914-20. doi: 10.1111/j.1464-410X.2012.11658.x. Epub 2013 Jan 15.
    PMID: 23320782 Free Article
    Similar articles
    Select item 23274971
24. Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.
    Yoneyama T, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda MN, Ohyama C.
    Transplantation. 2013 Feb 15;95(3):418-25. doi: 10.1097/TP.0b013e3182795b9c.
    PMID: 23274971
    Similar articles
    Select item 23254785
25. [Metastatic renal tumor from oral floor cancer: a case report].
    Ishibashi Y, Hatakeyama S, Okamoto T, Suzuki Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Sakaki H, Kobayashi W, Kimura H, Ohyama C.
    Hinyokika Kiyo. 2012 Nov;58(11):609-12. Japanese.
    PMID: 23254785 Free Article
    Similar articles
    Select item 23237922
26. Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma.
    Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T.
    Anticancer Drugs. 2013 Mar;24(3):310-4. doi: 10.1097/CAD.0b013e32835c401c.
    PMID: 23237922
    Similar articles
    Select item 23165940
27. Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
    Okamoto T, Yoneyama MS, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C, Tsuboi S.
    Mol Med Rep. 2013 Feb;7(2):359-64. doi: 10.3892/mmr.2012.1189. Epub 2012 Nov 19.
    PMID: 23165940 Free PMC Article
    Similar articles
    Select item 23011100
28. Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.
    Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, Kamimura N.
    Int J Clin Oncol. 2013 Aug;18(4):724-30. doi: 10.1007/s10147-012-0447-z. Epub 2012 Jul 19.

2012

1. Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.
   Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N.
   Prostate Cancer Prostatic Dis. 2012 Dec;15(4):397-401. doi: 10.1038/pcan.2012.29. Epub 2012 Aug 14.
   PMID: 22890389
   Similar articles
   Select item 22863303
2. Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution.
   Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Kudoh S, Yoneyama T, Hashimoto Y, Kamimura N.
   Eur J Surg Oncol. 2012 Nov;38(11):1101-5. doi: 10.1016/j.ejso.2012.07.115. Epub 2012 Aug 3.
   PMID: 22863303
   Similar articles
   Select item 22827879
3. Unexpected outcome after sclerotherapy of simple renal cyst.
   Hashimoto Y, Imai A, Tokui N, Sasaki A, Saitoh H, Koie T, Ohyama C.
   BMC Nephrol. 2012 Jul 24;13:63. doi: 10.1186/1471-2369-13-63.
   PMID: 22827879 Free PMC Article
   Similar articles
   Select item 22548171
4. Skin perfusion pressure is a prognostic factor in hemodialysis patients.
   Hatakeyama S, Saito M, Ishigaki K, Yamamoto H, Okamoto A, Ishibashi Y, Murasawa H, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C.
   Int J Nephrol. 2012;2012:385274. doi: 10.1155/2012/385274. Epub 2012 Apr 2.
   PMID: 22548171 Free PMC Article
   Similar articles
   Select item 22542358
5. Sarcoidosis of the ureter.
   Hashimoto Y, Kudoh S, Yamamoto H, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C.
   Urology. 2012 Jun;79(6):e81-2. doi: 10.1016/j.urology.2012.02.045. Epub 2012 Apr 25.
   PMID: 22542358
   Similar articles
   Select item 22446589
6. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
   Suzuki Y, Sutoh M, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Habuchi T, Arai Y, Fukuda M, Ohyama C, Tsuboi S.
   Int J Oncol. 2012 Jun;40(6):1831-8. doi: 10.3892/ijo.2012.1411. Epub 2012 Mar 23.
   PMID: 22446589 Free PMC Article
   Similar articles
   Select item 22425488
7. Two opposing roles of O-glycans in tumor metastasis.
   Tsuboi S, Hatakeyama S, Ohyama C, Fukuda M.
   Trends Mol Med. 2012 Apr;18(4):224-32. doi: 10.1016/j.molmed.2012.02.001. Epub 2012 Mar 16. Review.
   PMID: 22425488 Free PMC Article
   Similar articles
   Select item 22343738
8. [Adrenal pheochromocytoma with multiple neurofibromatosis on the trunk].
   Tokui N, Okamoto T, Imanishi K, Sugiyama N, Suzuki Y, Ishimura H, Hatakeyama S, Kudoh S, Yoneyama T, Koie T, Kamimura N, Ohyama C.
   Hinyokika Kiyo. 2012 Jan;58(1):17-9. Japanese.
   PMID: 22343738 Free Article
   Similar articles
   Select item 22310594
9. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
   Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.
   Transplant Proc. 2012
   Jan;44(1):121-3. doi: 10.1016/j.transproceed.2011.11.022.
10. Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.
    Hatakeyama S, Yamamoto H, Okamoto A, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C.
    Int J Nephrol. 2012;2012:376128. doi: 10.1155/2012/376128. Epub 2012 Jan 12.

2011

1. [Clinical staging of prostate cancer: the significance and the problem].
   Koie T, Ohyama C.
   Nihon Rinsho. 2011 Jun;69 Suppl 5:310-3. Review. Japanese. No abstract available.
   PMID: 22207992
   Similar articles
   Select item 22198799
2. Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.
   Hashimoto Y, Imanishi K, Tokui N, Okamoto T, Okamoto A, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C.
   Int J Clin Oncol. 2013 Feb;18(1):177-82. doi: 10.1007/s10147-011-0363-7. Epub 2011 Dec 27.
   PMID: 22198799
   Similar articles
   Select item 22164331
3. Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.
   Hatakeyama S, Toikawa T, Okamoto A, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Suzuki Y, Sugiyama N, Imai A, Hashimoto Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Saitoh H, Funyu T, Ohyama C.
   Int J Nephrol. 2011;2011:464735. doi: 10.4061/2011/464735. Epub 2011 Nov 20.
   PMID: 22164331 Free PMC Article
   Similar articles
   Select item 22145865
4. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.
   Inoue T, Matsuura K, Yoshimoto T, Nguyen LT, Tsukamoto Y, Nakada C, Hijiya N, Narimatsu T, Nomura T, Sato F, Nagashima Y, Kashima K, Hatakeyama S, Ohyama C, Numakura K, Habuchi T, Nakagawa M, Seto M, Mimata H, Moriyama M.
   Cancer Sci. 2012 Mar;103(3):569-76. doi: 10.1111/j.1349-7006.2011.02176.x. Epub 2012 Jan 20.
   PMID: 22145865 Free Article
   Similar articles
   Select item 22114579
5. An aggressive signet ring cell carcinoma of the prostate in a Japanese man.
   Hashimoto Y, Imanishi K, Okamoto A, Sasaki A, Saitoh H, Wada R, Yamamoto H, Koie T, Ohyama C.
   Case Rep Oncol. 2011 Sep;4(3):517-20. doi: 10.1159/000334081. Epub 2011 Oct 17.
   PMID: 22114579 Free PMC Article
   Similar articles
   Select item 22114188
6. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
   Hatakeyama S, Sugihara K, Shibata TK, Nakayama J, Akama TO, Tamura N, Wong SM, Bobkov AA, Takano Y, Ohyama C, Fukuda M, Fukuda MN.
   Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19587-92. doi: 10.1073/pnas.1105057108. Epub 2011 Nov 23.
   PMID: 22114188 Free PMC Article
   Similar articles
   Select item 22028966
7. Clearance and safety of the radiocontrast medium iopamidol in peritoneal dialysis patients.
   Hatakeyama S, Abe A, Suzuki T, Hashimoto Y, Koie T, Funyu T, Satoh S, Habuchi T, Ohyama C, Matsuo S.
   Int J Nephrol. 2011;2011:657051. doi: 10.4061/2011/657051. Epub 2011 Oct 19.
   PMID: 22028966 Free PMC Article
   Similar articles
   Select item 21782374
8. Minimum incision endoscopic radical prostatectomy: clinical and oncological outcomes at a single institute.
   Koie T, Yamamoto H, Hatakeyama S, Kudoh S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C.
   Eur J Surg Oncol. 2011 Sep;37(9):805-10. doi: 10.1016/j.ejso.2011.06.009. Epub 2011 Jul 22.
   PMID: 21782374
   Similar articles
   Select item 21712812
9. A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.
   Tsuboi S, Sutoh M, Hatakeyama S, Hiraoka N, Habuchi T, Horikawa Y, Hashimoto Y, Yoneyama T, Mori K, Koie T, Nakamura T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C.
   EMBO J. 2011 Jun 28;30(15):3173-85. doi: 10.1038/emboj.2011.215.
   PMID: 21712812 Free PMC Article
   Similar articles
   Select item 21687624
10. A very long foreign body in the bladder.
    Imai A, Suzuki Y, Hashimoto Y, Sasaki A, Saitoh H, Ohyama C.
    Adv Urol. 2011;2011:323197. doi: 10.1155/2011/323197. Epub 2011 May 23.
    PMID: 21687624 Free PMC Article
    Similar articles
    Select item 21678041
11. Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.
    Hashimoto Y, Okamoto A, Imai A, Yoneyama T, Hatakeyama S, Yoneyama T, Koie T, Kaminura N, Ohyama C.
    Int J Clin Oncol. 2012 Apr;17(2):119-23. doi: 10.1007/s10147-011-0267-6. Epub 2011 Jun 16.
    PMID: 21678041
    Similar articles
    Select item 21421245
12. Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.
    Yamamoto H, Sutoh M, Hatakeyama S, Hashimoto Y, Yoneyama T, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.
    J Urol. 2011 May;185(5):1930-8. doi: 10.1016/j.juro.2010.12.027. Epub 2011 Mar 21.
    PMID: 21421245
    Similar articles
    Select item 21412038
13. [Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
    Kamimura N, Hatakeyama S, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Kawaguchi T, Takahashi S, Ohyama C.
    Hinyokika Kiyo. 2011 Feb;57(2):71-6. Japanese.

2010

1. Invadopodia formation by bladder tumor cells.
   Sutoh M, Hashimoto Y, Yoneyama T, Yamamoto H, Hatakeyama S, Koie T, Okamoto A, Yamaya K, Saitoh H, Funyu T, Nakamura T, Sato T, Ohyama C, Tsuboi S.
   Oncol Res. 2010;19(2):85-92.
   PMID: 21302809
   Similar articles
   Select item 21197426
2. Surgical treatment of a giant liposarcoma in a Japanese man.
   Hashimoto Y, Hatakeyama S, Tachiwada T, Yoneyama T, Koie T, Kamimura N, Yanagisawa T, Hakamada K, Ohyama C.
   Adv Urol. 2010;2010:943073. doi: 10.1155/2010/943073. Epub 2010 Dec 16.
   PMID: 21197426 Free PMC Article
   Similar articles
   Select item 21063164
3. [The giant schwannoma in the pelvic cavity: a case report].
   Suzuki Y, Sugiyama N, Okamoto A, Yamamoto H, Hatakeyama S, Yoneyama T, Hasimoto Y, Koie T, Kamimura N, Ohyama C.
   Hinyokika Kiyo. 2010 Oct;56(10):581-3. Japanese.
   PMID: 21063164 Free Article
   Similar articles
   Select item 21063160
4. [Experience of laparoscopic surgery of pheochromocytoma found on induction for hemodialysis].
   Sugiyama N, Suzuki Y, Okamoto A, Yamamoto H, Kudo S, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Ohyama C.
   Hinyokika Kiyo. 2010 Oct;56(10):565-7. Japanese.
   PMID: 21063160 Free Article
   Similar articles
   Select item 21063158
5. [Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].
   Iwabuchi I, Mori K, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Suzuki T, Ohyama C.
   Hinyokika Kiyo. 2010 Oct;56(10):551-7. Japanese.
   PMID: 21063158 Free Article
   Similar articles
   Select item 20816179
6. Tumor formation assays.
   Hatakeyama S, Yamamoto H, Ohyama C.
   Methods Enzymol. 2010;479:397-411. doi: 10.1016/S0076-6879(10)79023-6.
7. A case of adrenocortical oncocytoma occurring with aldosteronoma.
   Terui K, Sakihara S, Kageyama K, Nigawara T, Takayasu S, Matsuhashi Y, Kon A, Yamamoto H, Ohyama C, Sasano H, Suda T.
   J Clin Endocrinol Metab. 2010 Aug;95(8):3597-8. doi: 10.1210/jc.2009-2787. No abstract available.
   PMID: 20685888
   Similar articles
   Select item 20389164
8. Cauda equina symptoms are closely related to male lower urinary tract symptoms.
   Imai A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Danjo K, Ono A, Ohyama C.
   Urol Int. 2010;84(3):325-9. doi: 10.1159/000288237. Epub 2010 Apr 13.
   PMID: 20389164
   Similar articles
   Select item 20185993
9. [Relationship between tumor volume and PSA recurrence after radical prostatectomy].
   Hashimoto Y, Momose A, Okamoto A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Koie T, Kamimura N, Ohyama C.
   Hinyokika Kiyo. 2010 Feb;56(2):91-4. Japanese.

2009

1. [Multiple inflammatory pseudotumor of the paranephric fat].
   Yamamoto H, Suzuki Y, Sugiyama N, Okamoto A, Hatakeyama S, Iwabuchi I, Yoneyama T, Koie T, Hashimoto Y, Momose A, Kamimura N, Ohyama C.
   Hinyokika Kiyo. 2009 Dec;55(12):757-9. Japanese.
   PMID: 20048560 Free Article
   Similar articles
   Select item 24710046
2. Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer.
   Kido T, Hatakeyama S, Ohyama C, Lau YF.
   Genes (Basel). 2010 Sep 14;1(2):283-93. doi: 10.3390/genes1020283.
   PMID: 24710046 Free PMC Article
   Similar articles
   Select item 20017138
3. Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.
   Hatakeyama S, Kyan A, Yamamoto H, Okamoto A, Sugiyama N, Suzuki Y, Yoneyama T, Hashimoto Y, Koie T, Yamada S, Saito H, Arai Y, Fukuda M, Ohyama C.
   Int J Cancer. 2010 Sep 1;127(5):1052-9. doi: 10.1002/ijc.25117.
   PMID: 20017138 Free PMC Article
   Similar articles
   Select item 19969331
4. Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.
   Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C.
   Urology. 2010 Jun;75(6):1499-503. doi: 10.1016/j.urology.2009.08.083. Epub 2009 Dec 6.
   PMID: 19969331
   Similar articles
   Select item 19954754
5. Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation.
   Yoshida H, Metoki N, Ishikawa A, Imaizumi T, Matsumiya T, Tanji K, Ota K, Ohyama C, Satoh K.
   Neurosci Res. 2010 Mar;66(3):284-9. doi: 10.1016/j.neures.2009.11.011. Epub 2009 Nov 30.
   PMID: 19954754
   Similar articles
   Select item 19917352
6. Role of peroxynitrite and recombinant human manganese superoxide dismutase in reducing ischemia-reperfusion renal tissue injury.
   Rahman NA, Mori K, Mizukami M, Suzuki T, Takahashi N, Ohyama C.
   Transplant Proc. 2009 Nov;41(9):3603-10. doi: 10.1016/j.transproceed.2009.04.008.
   PMID: 19917352
   Similar articles
   Select item 19880377
7. Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.
   Iida K, Mimura J, Itoh K, Ohyama C, Fujii-Kuriyama Y, Shimazui T, Akaza H, Yamamoto M.
   J Biochem. 2010 Mar;147(3):353-60. doi: 10.1093/jb/mvp169. Epub 2009 Oct 29.
   PMID: 19880377
   Similar articles
   Select item 19764532
8. [Solitary fibrous tumor of the kidney: a case report].
   Yoneyama T, Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Hashimoto Y, Kamimura N, Ohyama C.
   Hinyokika Kiyo. 2009 Aug;55(8):479-81. Japanese.
   PMID: 19764532 Free Article
   Similar articles
   Select item 19708864
9. Risk factors for erectile dysfunction in healthy Japanese men.
   Imai A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Danjyo K, Ohyama C.
   Int J Androl. 2010 Aug 1;33(4):569-73. doi: 10.1111/j.1365-2605.2009.00974.x. Epub 2009 Aug 25.
   PMID: 19708864
   Similar articles
   Select item 19395705
10. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.
    Lee SH, Hatakeyama S, Yu SY, Bao X, Ohyama C, Khoo KH, Fukuda MN, Fukuda M.
    J Biol Chem. 2009 Jun 19;284(25):17157-69. doi: 10.1074/jbc.M109.010934. Epub 2009 Apr 24.
    PMID: 19395705 Free PMC Article
    Similar articles
    Select item 19301611
11. [Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure].
    Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Yoneyama T, Hashimoto Y, Momose A, Kamimura N, Ohyama C.
    Hinyokika Kiyo. 2009 Feb;55(2):75-8. Japanese.
    PMID: 19301611 Free Article
    Similar articles
    Select item 19298350
12. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
    Koie T, Yoneyama T, Hashimoto Y, Kamimura N, Kusumi T, Kijima H, Ohyama C.
    Int J Urol. 2009 Mar;16(3):333-5. doi: 10.1111/j.1442-2042.2008.02231.x.
    PMID: 19298350 Free Article
    Similar articles
    Select item 19218775
13. Endothelial cyst of the adrenal gland associated with adrenocortical adenoma: preoperative images simulate carcinoma.
    Nigawara T, Sakihara S, Kageyama K, Terui K, Takayasu S, Hatakeyama S, Ohyama C, Sasano H, Suda T.
    Intern Med. 2009;48(4):235-40. Epub 2009 Feb 16.
    PMID: 19218775 Free Article
    Similar articles
    Select item 19218444
14. Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells.
    Hatakeyama S, Sugihara K, Nakayama J, Akama TO, Wong SM, Kawashima H, Zhang J, Smith DF, Ohyama C, Fukuda M, Fukuda MN.
    Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3095-100. doi: 10.1073/pnas.0810110106. Epub 2009 Feb 13.
    PMID: 19218444 Free PMC Article
    Similar articles
    Select item 19155218
15. FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in Macrophages.
    Tsuboi S, Takada H, Hara T, Mochizuki N, Funyu T, Saitoh H, Terayama Y, Yamaya K, Ohyama C, Nonoyama S, Ochs HD.
    J Biol Chem. 2009 Mar 27;284(13):8548-56. doi: 10.1074/jbc.M805638200. Epub 2009 Jan 20.
    PMID: 19155218 Free PMC Article
    Similar articles
    Select item 19082445
16. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C.
    Oncol Rep. 2009 Jan;21(1):73-9.

2008

1. [Surgical repair of persistent ileal neobladder-vaginal fistula using gracilis muscular flap: a case report].
   Okamoto A, Koie T, Hashimoto Y, Kamimura N, Ohyama C, Ishimura H, Narita S.
   Hinyokika Kiyo. 2008 Oct;54(10):673-6. Japanese.221.
   Immunohistochemical detection of carcinoma in radical prostatectomy specimens following hormone therapy.
   Kusumi T, Koie T, Tanaka M, Matsumoto K, Sato F, Kusumi A, Ohyama C, Kijima H.
   Pathol Int. 2008 Nov;58(11):687-94. doi: 10.1111/j.1440-1827.2008.02294.x.
   PMID: 18844933
   Similar articles
   Select item 18788444
2. ※エクセルに221なし
3. [Survey on informed consent about operative mortality in urologic surgery in Japan].
   Mitsuzuka K, Ishidoya S, Saito S, Ohyama C, Arai Y.
   Hinyokika Kiyo. 2008 Aug;54(8):543-8. Japanese.
   PMID: 18788444 Free Article
   Similar articles
   Select item 18776705
4. Progression of atherosclerosis in hemodialysis patients: effect of adiponectin on carotid intima media thickness.
   Tsushima M, Terayama Y, Momose A, Funyu T, Ohyama C.
   J Atheroscler Thromb. 2008 Aug;15(4):213-8.
   PMID: 18776705 Free Article
   Similar articles
   Select item 18704630
5. Glycosylation in bladder cancer.
   Ohyama C.
   Int J Clin Oncol. 2008 Aug;13(4):308-13. doi: 10.1007/s10147-008-0809-8. Epub 2008 Aug 15. Review.
   PMID: 18704630
   Similar articles
   Select item 18554632
6. Enhancement of human sperm motility by trophinin binding peptide.
   Hatakeyama S, Sugihara K, Lee SH, Nadano D, Nakayama J, Ohyama C, Fukuda MN.
   J Urol. 2008 Aug;180(2):767-71. doi: 10.1016/j.juro.2008.03.185. Epub 2008 Jun 13. Erratum in: J Urol. 2010 May;183(5):2102.
   PMID: 18554632
   Similar articles
   Select item 18505427
7. Involvement of retinoic acid-inducible gene-I in inflammation of rheumatoid fibroblast-like synoviocytes.
   Imaizumi T, Arikawa T, Sato T, Uesato R, Matsumiya T, Yoshida H, Ueno M, Yamasaki S, Nakajima T, Hirashima M, Sakata K, Ishibashi Y, Toh S, Ohyama C, Satoh K.
   Clin Exp Immunol. 2008 Aug;153(2):240-4. doi: 10.1111/j.1365-2249.2008.03685.x. Epub 2008 May 26.
   PMID: 18505427 Free PMC Article
   Similar articles
   Select item 18323673
8. A male case of nonclassical 21-hydroxylase deficiency first manifested in his sixties with adrenocortical incidentaloma.
   Nigawara T, Kageyama K, Sakihara S, Takayasu S, Kawahara M, Imai A, Ohyama C, Usui T, Sasano H, Suda T.
   Endocr J. 2008 May;55(2):291-7. Epub 2008 Mar 7.
   PMID: 18323673 Free Article
   Similar articles
   Select item 18304217
9. Frequency of postoperative inguinal hernia after endoscope-assisted mini-laparotomy and conventional retropubic radical prostatectomies.
   Koie T, Yoneyama T, Kamimura N, Imai A, Okamoto A, Ohyama C.
   Int J Urol. 2008 Mar;15(3):226-9. doi: 10.1111/j.1442-2042.2007.01983.x. Erratum in: Int J Urol. 2008 May;15(5):465.
   PMID: 18304217 Free Article
   Similar articles
   Select item 18279920
10. Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study.
    Yoneyama T, Ohyama C, Imai A, Ishimura H, Hagisawa S, Iwabuchi I, Mori K, Kamimura N, Koie T, Yamato T, Suzuki T.
    Urology. 2008 Jun;71(6):1161-5. doi: 10.1016/j.urology.2007.11.080. Epub 2008 Feb 15.
    PMID: 18279920
    Similar articles
    Select item 18260358
11. [Persistent Müllerian duct syndrome diagnosed by laparoscopic examination: a case report].
    Ishimura H, Okamoto A, Imai A, Iwabuchi I, Yoneyama T, Koie T, Yamato T, Kamimura N, Narita S, Ohyama C.
    Hinyokika Kiyo. 2008 Jan;54(1):35-7. Japanese.
    PMID: 18260358 Free Article
    Similar articles
    Select item 18195533
12. [Short-term outcome of neoadjuvant gemcitabine-carboplatin therapy for muscle-invasive bladder cancer].
    Yamato T, Okamoto A, Imai A, Ishimura D, Hatakeyama S, Hagisawa S, Iwabuchi I, Yoneyama T, Mori K, Koie T, Ohyama C.
    Gan To Kagaku Ryoho. 2008 Jan;35(1):83-6. Japanese.
    PMID: 18195533
    Similar articles
    Select item 18184171
13. Carotid intima media thickness and aortic calcification index closely relate to cerebro- and cardiovascular disorders in hemodialysis patients.
    Tsushima M, Terayama Y, Momose A, Funyu T, Ohyama C, Hada R.
    Int J Urol. 2008 Jan;15(1):48-51; discussion 51-2. doi: 10.1111/j.1442-2042.2007.01925.x.
    PMID: 18184171 Free Article
    Similar articles
    Select item 18097551
14. Positive expressions of N-acetylglucosaminyltransferase-V (GnT-V) and beta1-6 branching N-linked oligosaccharides in human testicular germ cells diminish during malignant transformation and progression.
    Kyan A, Kamimura N, Hagisawa S, Hatakeyama S, Koie T, Yoneyama T, Arai Y, Nakagawa H, Nishimura S, Miyoshi E, Hashimoto Y, Ohyama C.
    Int J Oncol. 2008 Jan;32(1):129-34.
    PMID: 18097551
    Similar articles
    Select item 17956937
15. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
    Tajiri M, Ohyama C, Wada Y.
    Glycobiology. 2008 Jan;18(1):2-8. Epub 2007 Oct 23.

2007

1. [Adenocarcinoma of the ileal segment 40 years after ileocystoplasty: a case report].
   Yoneyama T, Okamoto A, Imai A, Ishimura H, Hagisawa S, Iwabuchi I, Koie T, Yamato T, Ohyama C.
   Hinyokika Kiyo. 2007 Aug;53(8):589-91. Japanese.
   PMID: 17874554 Free Article
   Similar articles
   Select item 17705808
2. JKT-1 is not a human seminoma cell line.
   de Jong J, Stoop H, Gillis AJ, van Gurp RJ, van Drunen E, Beverloo HB, Lau YF, Schneider DT, Sherlock JK, Baeten J, Hatakeyama S, Ohyama C, Oosterhuis JW, Looijenga LH.
   Int J Androl. 2007 Aug;30(4):350-65.
   PMID: 17705808
   Similar articles
   Select item 17521702
3. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.
   Li Y, Tabatabai ZL, Lee TL, Hatakeyama S, Ohyama C, Chan WY, Looijenga LH, Lau YF.
   Hum Pathol. 2007 Oct;38(10):1470-81. Epub 2007 May 22.
   PMID: 17521702 Free PMC Article
   Similar articles
   Select item 17487845
4. The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer.
   Harada O, Suga T, Suzuki T, Nakamoto K, Kobayashi M, Nomiyama T, Nadano D, Ohyama C, Fukuda MN, Nakayama J.
   Int J Cancer. 2007 Sep 1;121(5):1072-8.
   PMID: 17487845 Free Article
   Similar articles
   Select item 17449641
5. Double-stranded RNA induces galectin-9 in vascular endothelial cells: involvement of TLR3, PI3K, and IRF3 pathway.
   Imaizumi T, Yoshida H, Nishi N, Sashinami H, Nakamura T, Hirashima M, Ohyama C, Itoh K, Satoh K.
   Glycobiology. 2007 Jul;17(7):12C-5C. Epub 2007 Apr 20